Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short-term Investments Total Current Liabilities Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Others

CorMedix (CRMD) Goodwill & Intangibles (2019 - 2025)

CorMedix has reported Goodwill & Intangibles over the past 4 years, most recently at $423.1 million for Q4 2025.

Quarterly results put Goodwill & Intangibles at $423.1 million for Q4 2025, up 21055.1% from a year ago — trailing twelve months through Dec 2025 was $423.1 million (up 21055.1% YoY), and the annual figure for FY2025 was $423.1 million, up 21055.1%.
Goodwill & Intangibles reached $423.1 million in Q4 2025 per CRMD's latest filing, up from $411.4 million in the prior quarter.
Across five years, Goodwill & Intangibles topped out at $423.1 million in Q4 2025 and bottomed at $1.7 million in Q2 2025.